2022 Speakers

Adrian Hobson

Senior Research Fellow, Drug Discovery Science & Technology Antibody-Drug Conjugates

AbbVie

Jagath Reddy Junutula

President, Chief Executive Officer & Co-Founder

Aarvik Therapeutics

Jixin Wang

Associate Director, Oncology Bioinformatics

AstraZeneca

Yu Shen

Director, Oncology Discovery

AbbVie

John Lambert

Consultant

Attager Consulting

Rakesh Dixit

Chief Executive Officer

Bionavigen

Sayumi Yamazoe

Senior Principal Scientist

Bristol-Myers Squibb

Seema Kantak

Senior Vice President, Biotherapeutics

Exelixis

Anikó Pálfi

Director, Biochemistry & Cell Biology

Heidelberg Pharma Research GmbH

Christopher Shelton

Scientific Director, Tumor Cell Targeting Research Unit

GlaxoSmithKline

Ed Ha

Head, ADC Innovation

Iksuda Therapeutics

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Dowdy Jackson

Executive Director, ADC Biology Research

Innovent Biologics

John DaSilva

Associate Director, Oncology & Immuno-Oncology

Regeneron

Robert Lawrence

Senior Scientist

Seagen

Thomas Nittoli

Senior Director, R&D Chemistry

Regeneron

Annette Vogl

Director, Biology & Translational Research

Tubulis GmbH

Jamie Rich

Director, Antibody- Drug Conjugate Technology & Therapeutic Development

Zymeworks